Niche leadership Nexus CMF holds a unique position as the only FDA-approved partial TMJ prosthesis manufacturer and the only US maker of both stock and patient-specific TMJ prostheses, signaling a defensible niche that can be leveraged to target TMJ specialists and craniofacial surgeons.

Targeted market With a focus on cranio-maxillofacial devices and expanding orthognathic solutions, there are near-term growth opportunities by selling into TMJ clinics, CMF centers, and hospitals performing complex craniofacial reconstructions.

Growth readiness Small but specialized team positions Nexus CMF to be agile in marketing high-value, customized implants; potential partnerships with larger CMF players or surgical centers could scale adoption and access to patient-specific solutions.

Strategic leverage The ability to offer both stock and patient-specific prostheses creates a compelling value proposition for surgeons seeking customization without compromising availability, enabling cross-sell opportunities to orthognathic and CMF procedures.

Financial signal Current revenue range and niche FDA-approved product suggest a sales strategy that prioritizes high-margin implants, aftercare services, and education programs to accelerate order size and repeat purchases within specialized CMF workflows.